Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pfizer
Scientific Title
A Phase 1 Study Of PF-05082566 As A Single Agent In Patients With Advanced Cancer, And In Combination With Rituximab In Patients With Non-Hodgkin's Lymphoma (NHL)